Manish Potti - 16 Dec 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
By: /s/ Manish Potti by Sanjay Subramanian, his attorney-in-fact
Issuer symbol
OCGN
Transactions as of
16 Dec 2021
Net transactions value
+$64,530
Form type
4
Filing time
17 Dec 2021, 20:24:13 UTC
Previous filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Options Exercise $6,885 +13,500 $0.5100 13,500 16 Dec 2021 Direct
transaction OCGN Common Stock Options Exercise $57,645 +31,500 +233% $1.83 45,000 16 Dec 2021 Direct
holding OCGN Common Stock 27,695 16 Dec 2021 Held by Scotland Parkway LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +16,335 $0.000000 16,335 16 Dec 2021 Common Stock 16,335 $5.02 Direct F2
transaction OCGN Option (Right to Buy) Options Exercise $0 +13,500 +225% $0.000000 19,500 16 Dec 2021 Common Stock 13,500 $0.5100 Direct F3
transaction OCGN Option (Right to Buy) Options Exercise $0 +31,500 +56% $0.000000 87,500 16 Dec 2021 Common Stock 31,500 $1.83 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is a managing member of Scotland Parkway LLC and has voting and investment power over securities held by Scotland Parkway LLC.
F2 The option vests monthly in equal installments over three years commencing on January 16, 2022, subject to continued service with Ocugen, Inc. (the "Company") on the applicable vesting dates.
F3 The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the second day of each month through January 2, 2023, subject to the Reporting Person's continued service with the Company through each such date.
F4 The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through January 1, 2024, subject to the Reporting Person's continued service with the Company through each such date.